A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the d… ...

During this time, compounded versions became a more accessible option. Now, brand-name GLP-1 injections of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are available again.

The "knock-off" versions of semaglutide emerged to fill a void when Wegovy was on the FDA's drug shortage list, and it led to "the lower-than-planned penetration of branded GLP-1s", as the CFO ...

Novo Nordisk is preparing to launch Wegovy in India, where millions of people are battling obesity and demand for the weight-loss drug is expected to be massive. The drug will be launched in ...

During this time, compounded versions became a more accessible option. Now, brand-name GLP-1 injections of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are available again.

The OFA had argued that Novo Nordisk, which manufacturers semaglutide, even acknowledged that compounded drugs satisfied 20 percent of the market, but Pittman noted that it seems they misread the ...

A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the drugs, was ...

On June 23, Novo Nordisk (NVO) abruptly walked away from their Wegovy distribution pact, calling Hims' parallel sale of compounded semaglutide "deceptive marketing." ...

Ozempic and Wegovy include the same compound, semaglutide, a GLP-1 receptor agonist. While Ozempic was first approved in 2017, Wegovy was approved later in 2021.